Get started
Author

Chineze Ivenso

Observed names: C Ivenso, C. Ivenso
ORCID: 0009-0003-3690-2698
Observed ORCID: 0009-0003-3690-2698
OpenAlex ID: A5002161236
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Eugenia Abaleke, Mustafa Abbas, et al. · The Lancet · 549
PDF
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 499
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 386
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 337
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 298
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · Obbina Abani, Ali Abbas, et al. · The Lancet · 134
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41
PDF
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 40
PDF
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12
PDF
Lecanemab appropriate use recommendations for clinical practice in the UK
2025 · Catherine J Mummery, Jill Rasmussen, et al. · Journal of Neurology Neurosurgery & Psychiatry · 11
PDF
Adapted problem adaptation therapy for depression in mild to moderate Alzheimer's disease dementia: A randomized controlled trial
2024 · Robert Howard, Elizabeth Cort, et al. · Alzheimer s & Dementia · 11
PDF
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O. Abani, A. Abbas, et al. · EClinicalMedicine · 6
Three approaches to determining clinically meaningful benefit on the Cohen‐Mansfield Agitation Inventory in dementia clinical trials for agitation
2025 · Kathy Y. Liu, Chineze Ivenso, et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 4
PDF
Delivering disease modifying treatments in Alzheimer's disease—An old age psychiatry UK perspective
2023 · Robert Barber, Chineze Ivenso, et al. · International Journal of Geriatric Psychiatry · 3
Development of the Clinical Insight Questionnaire: A Novel Clinical Tool for the Assessment of Insight Into Cognitive Symptoms and Everyday Functioning in People With Neurodegeneration
2025 · Catherine Pennington, Harriet Ball, et al. · International Journal of Geriatric Psychiatry · 2
PDF
A network and thematic analysis of mental health-related Prevention of Future Death reports from 2013 to 2025 in England and Wales
2026 · Hongyi Qin, Josie Jenkinson, et al. · The British Journal of Psychiatry · 1
PDF
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 1
PDF
Diagnosis of Alzheimer's disease before dementia: A study of UK psychiatrists
2021 · Madeleine Walpert, Susan Mitchell, et al. · Alzheimer s & Dementia
Works count: 21
Citation count: 2,394
H-index: 11
I10-index: 13
Year
Topic
Type